Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | NUVL | NUVALENT INC | Healthcare | 81,200.0 | $8.3M | 1.03% | -82K | -50.3% | $102.45 | -2.9% |
| 42 | WAY | WAYSTAR HLDG CORP | Technology | 342,566.0 | $8.3M | 1.02% | NEW | — | $24.11 | -17.0% |
| 43 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 1,438,625.0 | $8.0M | 0.98% | +200K | +16.1% | $5.55 | — |
| 44 | MDT | MEDTRONIC PLC | Healthcare | 90,000.0 | $7.8M | 0.96% | -206K | -69.6% | $86.65 | -10.8% |
| 45 | OSCR | OSCAR HEALTH INC | Healthcare | 660,000.0 | $7.6M | 0.93% | +400K | +153.8% | $11.47 | +115.2% |
| 46 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 2,055,327.0 | $7.2M | 0.89% | +460K | +28.8% | $3.51 | -5.3% |
| 47 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 263,071.0 | $7.1M | 0.88% | +120K | +84.5% | $27.09 | -2.6% |
| 48 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 92,900.0 | $7.0M | 0.86% | -66K | -41.4% | $75.09 | -3.5% |
| 49 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 81,627.0 | $6.9M | 0.84% | -17K | -17.2% | $83.92 | +0.6% |
| 50 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 90,600.0 | $6.7M | 0.83% | +9K | +11.0% | $74.26 | -12.3% |
| 51 | — | APOGEE THERAPEUTICS INC | — | 75,000.0 | $6.3M | 0.78% | NEW | — | $84.17 | — |
| 52 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 128,100.0 | $6.2M | 0.76% | -20K | -13.2% | $48.20 | -25.0% |
| 53 | CAH | CARDINAL HEALTH INC | Healthcare | 27,000.0 | $5.7M | 0.70% | NEW | — | $211.31 | -5.2% |
| 54 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 56,263.0 | $5.4M | 0.67% | -90K | -61.5% | $96.73 | +5.4% |
| 55 | AMGN | AMGEN INC | Healthcare | 15,200.0 | $5.3M | 0.66% | -21K | -57.8% | $351.85 | -8.3% |
| 56 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 160,000.0 | $5.2M | 0.64% | +77K | +92.8% | $32.54 | -12.5% |
| 57 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 313,500.0 | $4.9M | 0.60% | -224K | -41.7% | $15.50 | +0.1% |
| 58 | ALKS | ALKERMES PLC | Healthcare | 133,250.0 | $4.7M | 0.58% | — | — | $35.36 | +4.5% |
| 59 | CRL | CHARLES RIV LABS INTL INC | Healthcare | 26,000.0 | $4.5M | 0.55% | +4K | +18.2% | $172.50 | -13.9% |
| 60 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 239,500.0 | $4.5M | 0.55% | -124K | -34.2% | $18.64 | -13.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.9%
Technology
1.1%